Effect of TyG Index on Outcomes of Radical Prostatectomy

Prostate Cancer Clinical Trial

— TyG-PCa  

Official title:

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03447028
• Other study ID #: Recepteutrh
• Status: Completed
• Phase: N/A
• First received: February 20, 2018
• Last updated: February 24, 2018
• Start date: January 1, 2007
• Est. completion date: December 30, 2012

Study information

• Verified date: February 2018
• Source: Recep Tayyip Erdogan University Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

Description:

TyG index is calculated with special formula. Patients undergoing radical prostatectomy are divided two groups according to the cut-off level of 8.55 for TyG index.Groups were compared statistically in terms of oncological outcomes and survival.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 30, 2012
• Est. primary completion date: December 30, 2012
• Accepts healthy volunteers: No
• Gender: Male
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients undergoing radical prostatectomy for prostate cancer

Exclusion Criteria:

• taking medicines for established diabetes and dyslipidaemia,

• presence of endocrinological disease,

• history of bariatric surgery,

• missing data and patients with uncontrolled follow-up

Related Conditions & MeSH terms

• Insulin Resistance
• Metabolic Syndrome
• Metabolic Syndrome X
• Prostate Cancer
• Prostatic Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Recep Tayyip Erdogan University Training and Research Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oncological outcomes	Effect of TyG index on oncological outcomes of Prostate cancer	5 years
Secondary	Survival	Death date of patient after radical prostatectomy	5 years